The Board of Directors, in a meeting held on 25 March 2025, declared an interim dividend of Rs 25 per equity share on a face ...
The U.S. Food and Drug Administration approved French drugmaker Sanofi's hemophilia therapy, introducing a new type of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback